Argus Research Maintains Buy on GE HealthCare Techs, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst David Toung maintains a Buy rating on GE HealthCare Techs (NASDAQ:GEHC) and raises the price target from $80 to $110.
April 01, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research maintains a Buy rating on GE HealthCare Techs and increases the price target from $80 to $110.
The upgrade in the price target by Argus Research indicates a positive outlook on GE HealthCare Techs' stock, suggesting potential for growth. This is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100